Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2019-001343-44-ES
EUCTR2019-001343-44-ES
Active, not recruiting
Phase 1

Conventional ovarian stimulation vs. stimulation with single injection of Corifollitropin alfa in oocyte donors. Randomized clinical trial. Tail Studio - TAIL study

Instituto Bernabeu0 sites180 target enrollmentApril 30, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsElonva

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Instituto Bernabeu
Enrollment
180
Status
Active, not recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 30, 2019
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
Instituto Bernabeu

Eligibility Criteria

Inclusion Criteria

  • •1\. To be considered fit to enter the Bernabeu Institute oocyte donation program (Annex I)
  • •2\. Age between 18 and 32 years
  • •3\. BMI\> 18 and \<30
  • •4\. Antral follicle count\> 12 (adding both ovaries)
  • •5\. Presence of both ovaries
  • •6\. Ability to participate and comply with the study protocol
  • •7\. Having given written consent
  • •8\. Not having received treatment with ovulation stimulators in the 3 months prior to the start of the stimulation.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:

Exclusion Criteria

  • •1\. Diagnosis of endometriosis at any stage
  • •2\. AFC\> 20
  • •4\. Concurrent participation in another study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Assessment the effect of ovarian stimulation with and without letrozole in IVF/ICSI outcomes.
IRCT201701291952N8Vice Chancellor for research, Tehran University of Medical Science160
Completed
Not Applicable
Comparison of controlled ovarian stimulation with clomiphen citrate HMG(Human menopausal gonadotropin) or clomiphen citrate rFSH(recombinant follicule stimulating hormon) in IUI(Intrauterine Insemination) cycles.Condition 1: Unexplained infertility. Condition 2: Male factor infertility.Female infertility, unspecifiedOligospermia NOS
IRCT201109163386N4Semnan University of Medical Sciences142
Active, not recruiting
Not Applicable
Fertility preservation in breast cancer patients: oocytes or embryos vitrification.The aim of this trial is to offer a safe and efficient alternative protocol to preserve fertility by storing oocytes in breast cancer patients before chemotherapy. Letrozole, an inhibitor of aromatase, is administered during standard gonadotropins ovarian stimulation to maintain a low estradiol level during ovarian stimulation in patients with hormono-sensitive tumour.MedDRA version: 18.1Level: LLTClassification code 10006190Term: Breast cancer invasive NOSSystem Organ Class: 100000004864MedDRA version: 18.1Level: LLTClassification code 10016465Term: Fertility female decreasedSystem Organ Class: 100000004872MedDRA version: 18.1Level: LLTClassification code 10016463Term: Fertility decreased femaleSystem Organ Class: 100000004872Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2012-003412-31-BECUB - Hôpital Erasme
Active, not recruiting
Phase 1
How do different ovarian stimulation protocols affect endometrial receptivity during a fresh in vitro fertilization attempt?
EUCTR2018-003556-20-PTINSTITUTO VALENCIANO DE INFERTILIDADE - CLÍNICA DE REPRODUÇÃO ASSISTIDA, LDA24
Completed
Not Applicable
Comparing the effects of ovarian stimulation in infertile patientsinfertility.Female infertility
IRCT20221001056068N1Esfahan University of Medical Sciences26